Guidance for the use and prescribing of PCSK9 inhibitors

Primary care guidance for the prescribing and supply of Inclisiran

Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD

Summary of national guidance for lipid management for primary and secondary prevention of cardiovascular disease

NHS South West Strategic Clinical Network - Top tips for managing AF

Clinical guidelines for Secondary Prevention after Stroke or TIA

Inhixa (enoxaparin biosimilar) Information sheet

2. In the management of patients with angina who are unsuitable for a beta-blocker, a rate limiting calcium-channel blocker is the first option. A switch to ivabradine may be considered if the calcium-channel blocker is ineffective in controlling heart rate or angina. In addition, relative hypotension may be a reason to choose ivabradine instead of trying a rate-limiting calcium-channel blocker.

3. NICE Chronic heart failure - ivabradine (TA267)